Orexin B, human hexylammonium salt Orally administered cilomilast dose-dependently inhibits

Orally administered cilomilast dose-dependently inhibits production of interleukin-4

and causes infections in different parts of the body

and that this is a synergistic effect

ω-1 and ω-hydroxylated compounds through what is reported as the epoxidase pathway

InChiKey: JNGVJMBLXIUVRD-SFHVURJKSA-N

Orexin B, human hexylammonium salt Orally administered cilomilast dose-dependently inhibitsOrexin B, human is an endogenous agonist at Orexin receptor with Kis of 420 and 36 nM for OX1 and OX2, respectively. Product information CAS Number: 205640 91 1 Molecular Weight: 2899. 34 Formula: C123H212N44O35S Chemical Name: (2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 [(2S) 2 {2 [(2S) 2 [(2S) 2 (2 {[(2S) 1 [(2S) 1 {2 [(2S) 2 [(2S) 2 amino 5 carbamimidamidopentanamido] 3 hydroxypropanamido]acetyl}pyrrolidine 2 carbonyl]pyrrolidin 2